Oncology & Cancer

Recruitment begins for world's first ovarian cancer vaccine trial

UConn Health is beginning to recruit patients for the world's first personalized genomics-driven ovarian cancer vaccine clinical trial. The goal: to prevent an often deadly relapse of the disease in women diagnosed at advanced ...

Oncology & Cancer

Study shows how ovarian cancer starts in high-risk women

Stem cell scientists have revealed the origins of a common ovarian cancer by modeling fallopian tube tissues, allowing them to   characterize how a genetic mutation puts women at high risk for this cancer. The created ...

Oncology & Cancer

New blood test developed to diagnose ovarian cancer

Investigators from Brigham and Women's Hospital and Dana-Farber Cancer Institute are leveraging the power of artificial intelligence to develop a new technique to detect ovarian cancer early and accurately. The team has identified ...

page 1 from 40